Toronto, Ontario–(Newsfile Corp. – August 14, 2024) – Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic” or the “Company“) announced today that the Company will be unable to file its annual audited consolidated financial statements for the financial year ended April 30, 2024, the related annual management’s discussion and analysis and the related CEO and CFO certifications (collectively, the “2024 Financial Disclosure“) by August 28, 2024 (the “Filing Deadline“) in accordance with the requirements of National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102“) and National I…